People_

Dr Arunan Sriravindrarajah

Clinical Lecturer
Sydney Medical School
Westmead Clinical School
Faculty of Medicine and Health

Email

Dr Sriravindrarajah is the Clinical Superintendent (Medicine) and Staff Specialist Endocrinologist at Royal Prince Alfred Hospital.

Publications

Expand all

Journals

Sriravindrarajah, A., Holmes-Walker, J. (2024). Diabetic ketoacidosis – treatment and prevention. Endocrinology Today, 13(3), 37-40. [More Information]
Sriravindrarajah, A., Hurwitz, J., Lim, E., Greenfield, J. (2024). Hyperglycemia secondary to phosphatidylinositol-3 kinase (PI3K) inhibition. Endocrinology, Diabetes & Metabolism Case Reports, 2024 (4), 1-4. [More Information]
Sriravindrarajah, A., Fernandes, A., Wu, T., Hocking, S. (2021). The use of SGLT2 inhibitors in achieving glycaemic control in maturity-onset diabetes of the young type 3. Endocrinology, Diabetes & Metabolism Case Reports, 2021 (1). [More Information]
Sriravindrarajah, A., Kotwal, S., Sen, S., McDonald, S., Jardine, M., Cass, A., Gallagher, M. (2020). Impact of Supplemental Private Health Insurance on Dialysis and Outcomes. Internal Medicine Journal, 50(5), 542-549. [More Information]
Virk, S., Tian, D., Sriravindrarajah, A., Dunn, D., Wolfenden, H., Suri, R., Munkholm-Larsen, S., Cao, C. (2017). Mitral valve surgery and coronary artery bypass grafting for moderate-to-severe ischemic mitral regurgitation: Meta-analysis of clinical and echocardiographic outcomes. European Journal Of Cardio-Thoracic Surgery, 154(1), 127-136. [More Information]
Virk, S., Sriravindrarajah, A., Dunn, D., Liou, K., Wolfenden, H., Tan, G., Cao, C. (2015). A meta-analysis of mitral valve repair versus replacement for ischemic mitral regurgitation. Annals of Cardiothoracic Surgery, 4(5), 400-410. [More Information]

show 3 more

Expand all

2024

Sriravindrarajah, A., Holmes-Walker, J. (2024). Diabetic ketoacidosis – treatment and prevention. Endocrinology Today, 13(3), 37-40. [More Information]
Sriravindrarajah, A., Hurwitz, J., Lim, E., Greenfield, J. (2024). Hyperglycemia secondary to phosphatidylinositol-3 kinase (PI3K) inhibition. Endocrinology, Diabetes & Metabolism Case Reports, 2024 (4), 1-4. [More Information]

2021

Sriravindrarajah, A., Fernandes, A., Wu, T., Hocking, S. (2021). The use of SGLT2 inhibitors in achieving glycaemic control in maturity-onset diabetes of the young type 3. Endocrinology, Diabetes & Metabolism Case Reports, 2021 (1). [More Information]

2020

Sriravindrarajah, A., Kotwal, S., Sen, S., McDonald, S., Jardine, M., Cass, A., Gallagher, M. (2020). Impact of Supplemental Private Health Insurance on Dialysis and Outcomes. Internal Medicine Journal, 50(5), 542-549. [More Information]

2017

Virk, S., Tian, D., Sriravindrarajah, A., Dunn, D., Wolfenden, H., Suri, R., Munkholm-Larsen, S., Cao, C. (2017). Mitral valve surgery and coronary artery bypass grafting for moderate-to-severe ischemic mitral regurgitation: Meta-analysis of clinical and echocardiographic outcomes. European Journal Of Cardio-Thoracic Surgery, 154(1), 127-136. [More Information]

2015

Virk, S., Sriravindrarajah, A., Dunn, D., Liou, K., Wolfenden, H., Tan, G., Cao, C. (2015). A meta-analysis of mitral valve repair versus replacement for ischemic mitral regurgitation. Annals of Cardiothoracic Surgery, 4(5), 400-410. [More Information]